2021
Cost-efficiency and expanded access modeling of conversion to biosimilar trastuzumab-dkst with or without pertuzumab in metastatic breast cancer.
McBride, A., Macdonald, K., Fuentes-Alburo, A., & Abraham, I. (2021). Cost-efficiency and expanded access modeling of conversion to biosimilar trastuzumab-dkst with or without pertuzumab in metastatic breast cancer. 24(1). https://doi.org/10.1080/13696998.2021.1928515
Cycloartane- and Lanostane-Type Triterpenoids from the Resin of Parthenium argentatum AZ-2, a Byproduct of Guayule Rubber Production
Xu, Y.- ming, Madasu, C., Liu, P., Wijeratne, E., Dierig, D., White, L., Molnár, I., & Gunatilaka, A. (2021). Cycloartane- and Lanostane-Type Triterpenoids from the Resin of Parthenium argentatum AZ-2, a Byproduct of Guayule Rubber Production. 6(23).
Design and Comprehensive Characterization of Tetramethylpyrazine (TMP) for Targeted Lung Delivery as Inhalation Aerosols in Pulmonary Hypertension (PH): In Vitro Human Lung Cell Culture and In Vivo Efficacy.
Muralidharan, P., Acosta, M., Gomez, A., Grijalva, C., Tang, H., Yuan, J., & Mansour, H. (2021). Design and Comprehensive Characterization of Tetramethylpyrazine (TMP) for Targeted Lung Delivery as Inhalation Aerosols in Pulmonary Hypertension (PH): In Vitro Human Lung Cell Culture and In Vivo Efficacy. 10(3). https://doi.org/10.3390/antiox10030427
Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and Activity against .
Sutar, Y., Fulton, S., Paul, S., Altamirano, S., Mhatre, S., Saeed, H., Patel, P., Mallick, S., Bhat, R., Patravale, V., Chauhan, D., Nielsen, K., & Date, A. (2021). Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and Activity against . 7(9). https://doi.org/10.1021/acsinfecdis.1c00063
Drug Prescribing: Drug-Drug Interactions.
McQuade, B., & Campbell, P. (2021). Drug Prescribing: Drug-Drug Interactions. 508.
Drug Prescribing: Polypharmacy and Deprescribing.
McQuade, B., & Campbell, P. (2021). Drug Prescribing: Polypharmacy and Deprescribing. 508.
Early oral switch to combined cefixime therapy for management of osteoarticular infections in pediatric sickle cell disease patients: A descriptive analysis.
Mohzari, Y., Alshuraim, R., Asdaq, S., Aljobair, F., Alrashed, A., Alsowaida, Y., Alamer, A., Munjem, M., Musawa, M., Hatata, M., Alzaaqi, M., Binrokan, A., Alajlan, S., Abraham, I., & Alamer, A. (2021). Early oral switch to combined cefixime therapy for management of osteoarticular infections in pediatric sickle cell disease patients: A descriptive analysis. 15(1). https://doi.org/10.1016/j.jiph.2021.11.006
Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis.
Alamer, A., Alrashed, A., Alfaifi, M., Alosaimi, B., AlHassar, F., Almutairi, A., Howaidi, J., Almutairi, A., Mohzari, Y., Sulaiman, T., Al-Jedai, A., Alajami, H., Alkharji, F., Alsaeed, A., Alali, A., Baredhwan, A., Abraham, I., & Almulhim, A. (2021). Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis. 37(7). https://doi.org/10.1080/03007995.2021.1920900
Efficacy of personal pharmacogenomic testing as an educational tool in the pharmacy curriculum: A nonblinded, randomized controlled trial.
Grace, K., Larriva, M., Steiner, H., Marupuru, S., Campbell, P., Patterson, H., Cropp, C., Quinn, D., Klimecki, W., Nix, D., Warholak, T., & Karnes, J. (2021). Efficacy of personal pharmacogenomic testing as an educational tool in the pharmacy curriculum: A nonblinded, randomized controlled trial. 14(6). https://doi.org/10.1111/cts.13121
Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
Chinthammit, C., Axon, D., Mollon, L., Taylor, A., Pickering, M., Black, S., Warholak, T., & Campbell, P. (2021). Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study. 27(1). https://doi.org/10.18553/jmcp.2021.27.1.064
Evaluation of a Novel Pharmacist-Delivered Adherence Improvement Service via Telehealth.
Marupuru, S., Dhatt, H., Bingham, J., & Warholak, T. (2021). Evaluation of a Novel Pharmacist-Delivered Adherence Improvement Service via Telehealth. 9(3). https://doi.org/10.3390/pharmacy9030140
Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart Failure.
Alkhatib, N., Sweitzer, N., Lee, J., Erstad, B., Slack, M., Gharaibeh, M., Karnes, J., Klimecki, W., Ramos, K., & Abraham, I. (2021). Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart Failure. 21(2). https://doi.org/10.1007/s40256-020-00425-x
Expanding pharmacists' roles: Pharmacists' perspectives on barriers and facilitators to collaborative practice.
Lott, B., Anderson, E., Zapata, L., Cooley, J., Forbes, S., Taylor, A., Manygoats, T., & Warholak, T. (2021). Expanding pharmacists’ roles: Pharmacists’ perspectives on barriers and facilitators to collaborative practice. 61(2). https://doi.org/10.1016/j.japh.2020.11.024
Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancer.
Ray, A.-M., Salim, N., Stevens, M., Chitre, S., Abdeen, S., Washburn, A., Sivinski, J., O’Hagan, H., Chapman, E., & Johnson, M. (2021). Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancer. 40. https://doi.org/10.1016/j.bmc.2021.116129
FAM129B-dependent activation of NRF2 promotes an invasive phenotype in BRAF mutant melanoma cells.
Schmidlin, C., Tian, W., Dodson, M., Chapman, E., & Zhang, D. (2021). FAM129B-dependent activation of NRF2 promotes an invasive phenotype in BRAF mutant melanoma cells. 60(5). https://doi.org/10.1002/mc.23295
Formoterol PLGA-PEG Nanoparticles Induce Mitochondrial Biogenesis in Renal Proximal Tubules.
Vallorz, E., Blohm-Mangone, K., Schnellmann, R., & Mansour, H. (2021). Formoterol PLGA-PEG Nanoparticles Induce Mitochondrial Biogenesis in Renal Proximal Tubules. 23(4). https://doi.org/10.1208/s12248-021-00619-4
Function, Therapeutic Potential, and Inhibition of Hsp70 Chaperones.
Ambrose, A., & Chapman, E. (2021). Function, Therapeutic Potential, and Inhibition of Hsp70 Chaperones. 64(11). https://doi.org/10.1021/acs.jmedchem.0c02091
Functional Differences between E. coli and ESKAPE Pathogen GroES/GroEL.
Sivinski, J., Ambrose, A., Panfilenko, I., Zerio, C., Machulis, J., Mollasalehi, N., Kaneko, L., Stevens, M., Ray, A.-M., Park, H., Wu, C., Hoang, Q., Johnson, M., & Chapman, E. (2021). Functional Differences between E. coli and ESKAPE Pathogen GroES/GroEL. 12(1). https://doi.org/10.1128/mBio.02167-20
Gender-stratified hierarchical modeling of patient and physician determinants of antihypertensive treatment outcomes: pooled analysis of seven prospective real-world studies with 17,044 patients.
Hamarneh, D., Alkhatib, N., Denhaerynck, K., Vancayzeele, S., Brié, H., Macdonald, K., & Abraham, I. (2021). Gender-stratified hierarchical modeling of patient and physician determinants of antihypertensive treatment outcomes: pooled analysis of seven prospective real-world studies with 17,044 patients. 37(3). https://doi.org/10.1080/03007995.2021.1877124
Health Costs of Older Opioid Users with Pain and Comorbid Hypercholesterolemia or Hypertension in the United States
Axon, D., Marupuru, S., & Vaffis, S. (2021). Health Costs of Older Opioid Users with Pain and Comorbid Hypercholesterolemia or Hypertension in the United States.
Health Costs of Older Opioid Users with Pain and Comorbid Hypercholesterolemia or Hypertension in the United States.
Axon, D., Marupuru, S., & Vaffis, S. (2021). Health Costs of Older Opioid Users with Pain and Comorbid Hypercholesterolemia or Hypertension in the United States. 9(2). https://doi.org/10.3390/diseases9020041
Hierarchical modeling of blood pressure determinants and outcomes following valsartan treatment in hypertensive patients with known comorbidities: pooled analysis of six prospective real-world studies including 11,999 patients.
Alkhatib, N., Sun, B., Denhaerynck, K., Hamarneh, D., Van Camp, Y., Villa, L., Brié, H., Vancayzeele, S., Macdonald, K., & Abraham, I. (2021). Hierarchical modeling of blood pressure determinants and outcomes following valsartan treatment in hypertensive patients with known comorbidities: pooled analysis of six prospective real-world studies including 11,999 patients. 37(1). https://doi.org/10.1080/03007995.2020.1853082
Hypertension, cholesterol and diabetes medication adherence, health care utilization and expenditure in a Medicare Supplemental sample.
Campbell, P., Axon, D., Taylor, A., Smith, T., Pickering, M., Black, S., Warholak, T., & Chinthammit, C. (2021). Hypertension, cholesterol and diabetes medication adherence, health care utilization and expenditure in a Medicare Supplemental sample. 100(35). https://doi.org/10.1097/MD.0000000000027143
Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data.
Almutairi, A., Erstad, B., McBride, A., Slack, M., & Abraham, I. (2021). Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data. 20(4). https://doi.org/10.1080/14740338.2021.1877272
Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer Therapy.
Shroff, R., Chalasani, P., Wei, Y., Pennington, D., Quirk, G., Schoenle, M., Peyton, K., Uhrlaub, J., Ripperger, T., Jergović, M., Dalgai, S., Wolf, A., Whitmer, R., Hammad, H., Carrier, A., Scott, A., Nikolich-Žugich, J., Worobey, M., Sprissler, R., … Bhattacharya, D. (2021). Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer Therapy. https://doi.org/10.1101/2021.05.13.21257129
Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy.
Wang, L., Little, N., Chen, Q., Lambesis, K., Le, D., Han, W., Scott, A., & Lu, J. (2021). Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy. https://doi.org/10.1038/s41565-021-00950-z
Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection.
Eedara, B., Alabsi, W., Encinas-Basurto, D., Polt, R., Ledford, J., & Mansour, H. (2021). Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection. 13(7). https://doi.org/10.3390/pharmaceutics13071077
Initiation of Oseltamivir in Critically Ill Patients: Variations in Prescribing Practices.
Campbell, P., Vraney, J., Oman, N., Xie, C., & Erstad, B. (2021). Initiation of Oseltamivir in Critically Ill Patients: Variations in Prescribing Practices. 55(2). https://doi.org/10.1177/1060028020942513
Is there still a role for talimogene laherparepvec (T-VEC) in advanced melanoma? An indirect efficacy comparison of T-VEC plus ipilimumab combination therapy versus T-VEC alone as salvage therapy in unresectable metastatic melanoma.
Fazel, M., AlRawashdh, N., Alamer, A., Curiel-Lewandrowski, C., & Abraham, I. (2021). Is there still a role for talimogene laherparepvec (T-VEC) in advanced melanoma? An indirect efficacy comparison of T-VEC plus ipilimumab combination therapy versus T-VEC alone as salvage therapy in unresectable metastatic melanoma. 21(12). https://doi.org/10.1080/14712598.2022.1998450